This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structural features, including the dimethylamino and fluorophenyl groups, make it a valuable building block in the development of drugs targeting neurological and psychiatric disorders. It is often employed in the preparation of compounds that interact with neurotransmitter systems, particularly those involving serotonin and dopamine receptors. Additionally, its fluorinated aromatic ring enhances its metabolic stability, making it a preferred choice in the design of molecules with improved pharmacokinetic properties. The compound's versatility also extends to its use in research and development for creating novel therapeutic agents with potential applications in treating conditions such as depression, anxiety, and schizophrenia.